About
RMI Partners is a venture company with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies. In Eastern Europe and Russia, the company makes global investments in a variety of therapeutic areas. RMI Partners is currently managing the venture fund Rusnano MedInvest, that is created to develop innovative projects in the field of medicine and pharmaceutics. RMI Partners portfolio includes companies from Russia, USA, UK, and Israel, specializing in the development and marketing of innovative pharmaceutical and medical technologies.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 433 investors are based in Moscow, Moscow City, Russian Federation.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Moscow, Russian Federation
Contact Information
linkedin.com/in/••••••••
Find more investors like RMI
Search Investors